Our management team has a long track record of working successfully in developing pharmaceutical drugs.

Michael Mehler, Ph.D.


Dr. Michael Mehler brings to leon-nanodrugs over 25 years of experience holding significant leadership roles in the international pharma and biotechnology industries. In his previous tenure he was the CEO of SpePharm AG, Lucerne, a pan-European specialty pharma company focused on high-value specialty hospital products. Prior to that he led Riemser Arzneimittel AG, today Riemser Pharma GmbH, Greifswald, as CEO from 2009 to 2014  and guided the company through the sale to AXA Private Equity, today Ardian, in 2012. From 2003 to 2009 he served Actelion Pharmaceuticals, (Allschwil) in several senior executive roles, Michael started his long-time international career at Merck/MSD and Novartis.

Wolfgang Beier, Ph.D.


Dr. Wolfgang Beier is the Chief Scientific Officer and one of the main co-founder of leon-nanodrugs. He has 35 years of international R&D experience in the pharmaceutical industry and in the CRO-business. He held senior executive management R&D positions in various pharma companies (Byk Gulden, Akzo etc.) and he has deep experience with FDA/EMA drug approvals. He focused on drug development in oncology and was a founder and CEO of PFK Pharma Research (CRO), CEO of PFK-ILEX Oncology and co-founder and CEO of Onoclogy World, Munich.

Christian Nafe


Christian Nafe is the Chief Financial Officer of leon-nanodrugs.He brings in more than 25 years of successfully working in corporate finance, controlling and finance. Christian held leading management positions in different roles in worldwide operating companies, since 2000 with a focus on life sciences. During this time, he successfully managed numerous license contracts, asset and share deals as well as supply agreements. He recently served as CEO/CFO at BioNet Holding GmbH, BioNet Ventures GmbH and BioNet Pharma GmbH (former Scil Technology GmbH). Christian graduated with honors as Dipl. Kaufmann in Business Administration from University Regensburg.



By closing this message, you consent to our cookies on this device in accordance with our cookie policy. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our privacy policy.

Read more